Results 181 to 190 of about 8,427,027 (317)

On the axiomatic foundations of linear scale-space : Combining semi-group structure with causality vs. scale invariance

, 1996
The notion of multi-scale representation is essential to many aspects of early visual processing. This article deals with the axiomatic formulation of the special type of multi-scale representation known as scale-space representation.
Lindeberg, Tony
core  

Patient- and caregiver-reported outcome and experience measures for evaluating serious illness communication: An environmental scan. [PDF]

Palliat Care Soc Pract
Seow H, Arora AK, Jia Z, Zhang K, Melchionna G, Levine O, Simon J, Sanders JJ, Myers J.   +8 more
europepmc   +1 more source

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

Molecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola, Yasmine Illi, Anna Bircher, Marijn Wilmink, Rachele F. Malagutti, Solenn Ottié, Cordelia Schuler, Pedro A. Ruiz, Cheryl de Vallière, Klaus Seuwen, Gerhard Rogler, Martin Hausmann   +11 more
wiley   +1 more source

Development and validation of the Good Limb Position Management Scale for Stroke Patients with Hemiplegia by Nurses: a cross-sectional study. [PDF]

BMJ Open
Leng M, Dong Y, Liu B, Zhang X, Ji X, Sun F, Li M, Yang L, Chen X.   +8 more
europepmc   +1 more source

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

Molecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim, Hwiyeong Lee, Jin Hong, Daechan Park   +3 more
wiley   +1 more source

Implementation of SCALE-UP in First-Year Chemistry at an HBCU. [PDF]

J High Educ Theory Pract
Erebholo F, Chakafana G, Holder C, Hahn IF, Ndip EM, Njoki PN, Whittington D, Asojo OA.   +7 more
europepmc   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

Molecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq, Marc Terrones, Felicia Rodrigues Fortes, Anne Schepers, Alessia Denis, Christophe Deben, Ken Op de Beeck, Guy Van Camp, Geert Vandeweyer   +8 more
wiley   +1 more source

Correction: LncRNA SPINT1-AS1 enhances the Warburg effect and promotes the progression of osteosarcoma via the miR-135b-5p/PGAM1 axis. [PDF]

Cancer Cell Int
Wang J, Zhang N, Wang Y, Chen F, Wang L, Wang K, Yao X, Pan X.   +7 more
europepmc   +1 more source

ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer

Molecular Oncology, EarlyView.
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi, Mandy Berndt‐Paetz, Eileen Lerner, Gregoire Najjar, Anca Azoitei, Krishna Pal Singh, Shailendra Kumar Gupta, Olaf Wolkenhauer, Cagatay Günes, Otmar Huber, Marc‐Oliver Grimm, Daniel Steinbach   +11 more
wiley   +1 more source

The Howe Track Scale with Dead Rail ; Platform 43 Feet ; Shop No. 456176 ; Bill of Timber, Section at A. B., Y. Y. and Plan of Foundation

Blueprints of Howe Scale Company Howe Track Scale with dead rail, platform 43 feet long, showing the bill of timber supplies, sections at A. B., and Y. Y.
Howe Scale Company
core